| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Dongabgyn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Current Assets | 3.049 | 3.018 | 2.967 | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Receivables | 2.816 | 2.787 | 2.740 | - | - | - | - | - | - | - |
| Cash | 233 | 231 | 227 | - | - | - | - | - | - | - |
| Shareholders Funds | -26.277 | -26.009 | -25.569 | - | - | - | - | - | - | - |
| Social Capital | 90 | 89 | 88 | - | - | - | - | - | - | - |
| Debts | 29.326 | 29.027 | 28.536 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Dongabgyn S.r.l.